Cannabis forms of consumption: Joint, vaporizer, oil & concentrates

The most important thing: vaporizers deliver 40-56 % bioavailability compared to 25 % with a joint – without tar, without CO, without benzenes. For medical users, vaporizer or sublingual oil is the most pharmacologically sensible way.
At a glance:
  • Vaporizer delivers 40-56 % bioavailability – more than twice as efficient as a joint
  • Sublingual oil: onset of effect 15-45 min, no burn damage, can be dosed precisely
  • Smoking: 25 % bioavailability + tar, benzenes and CO – pharmacologically the worst

Why the form of consumption fundamentally determines the effect

The same type of cannabis can have completely different effects depending on how it is consumed. Bioavailability, onset of effect, duration of effect and the risk profile differ considerably between joint, vaporizer, oil, edibles and concentrates. For medical users, the choice of consumption form is a pharmacological decision.

A comparison of forms of consumption

Form of consumption Bioavailability Onset of action Duration of effect Risks
Joint (with tobacco) 25-27 % 1-5 min 1-3 h Tobacco nicotine, combustion, tar, CO
Joint (pure) 25-27 % 1-5 min 1-3 h Combustion, tar, CO – no nicotine
Vaporizer (flower) 40-56 % 1-3 min 1-3 h Minimal – no combustion smoke
Vaporizer (concentrate) 50-70 % 30-90 s 1-2 h Lipoid pneumonia with vitamin E acetate (e-cigarettes), minimal with pure extracts
Oil sublingual 13-19 % 15-45 min 4-6 h Minimal – no smoke, no combustion
Capsules/Edibles 4-20 % 30-120 min 4-8 h Unpredictability, 11-OH-THC formation
Topical (cream, gel) <1 % systemic 15-30 min (local) 2-4 h (local) Minimal – no systemic effect

Vaporizer: The safest form of inhalation

Vaporizing heats cannabis to 170-230°C – below the combustion temperature (250°C+). As a result:
– No combustion products (no tar, no CO, no benzenes)
– Active ingredient yield 40-56 % (vs. 25 % with the joint)
– Reduced respiratory symptoms: Abrams et al. 2007 (Clin Pharmacol Ther): Significantly fewer respiratory symptoms after 1 month of vaporizer use than in joint users

Optimal temperatures:
– 170-185°C: Mainly CBD and linalool; light, clear effect
– 185-200°C: THC, myrcene; full effect
– 200-230°C: All cannabinoids and terpenes; strongest effect; slightly smoky flavor

Concentrates: Hash, Rosin, Wax, Shatter

Traditional hashish: Compressed kief (trichomes); 15-40 % THC; oldest form of consumption. Not medically available in Germany.

Raisin (hot pressed): Solvent-free; full terpene retention; 50-70 % THC. Cleanest extraction.

BHO (butane extract) – Wax, Shatter: 60-90 % THC; solvent residues possible with poor quality. Only from certified manufacturers.

CO₂ extract: Medical standard; clean, defined concentration; basis for medicinal oil preparations.

Sublingual vs. oral: the difference in oils

Sublingual (under the tongue, hold for 60 sec.): Absorption directly via oral mucosa → bioavailability 13-19 %, onset of action 15-45 min. No first-pass effect.

Study highlight: Abrams 2007 (Clin Pharmacol Ther): After 1 month of vaporizer use, significantly fewer respiratory symptoms than in joint users. Same effect – without the lung damage of combustion.

Oral (swallow oil/capsule): First-pass effect in liver → THC → 11-OH-THC; lower but longer-lasting bioavailability; to be treated like edibles.

More on the topic:

FAQ: Cannabis forms of consumption

Summary

Form of consumption determines bioavailability (vaporizer 40-56 %, edibles 4-20 %), onset of effect (inhalation 1-5 min, oral 30-120 min) and risk profile (joint with tobacco = highest risk, vaporizer = lowest with inhalation). For medical use: vaporizer or sublingual oil are the preferred forms. Cannabis Edibles for the specifics of oral ingestion; vaporizer guide for in-depth temperature control.

Cannabis prescription online? Our teleclinic comparison shows all 31 providers in direct comparison – with prices, waiting times and real reviews. Free and independent.